CNTA vs. QURE
CNTA (Centessa Pharmaceuticals Limited) and QURE (uniQure N.V.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, CNTA returned 12.71%/yr vs -5.87%/yr for QURE. At a 0.24 correlation, their price movements are largely independent.
Performance
CNTA vs. QURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CNTA achieves a 58.74% return, which is significantly higher than QURE's 12.83% return.
CNTA
- 1D
- 0.20%
- 1M
- 0.28%
- YTD
- 58.74%
- 6M
- 34.58%
- 1Y
- 233.05%
- 3Y*
- 104.97%
- 5Y*
- 12.71%
- 10Y*
- —
QURE
- 1D
- 2.08%
- 1M
- -2.39%
- YTD
- 12.83%
- 6M
- 24.02%
- 1Y
- 56.34%
- 3Y*
- 11.25%
- 5Y*
- -5.87%
- 10Y*
- 8.62%
CNTA vs. QURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CNTA Centessa Pharmaceuticals Limited | 58.74% | 49.31% | 110.43% | 156.77% | -72.47% | -48.23% |
QURE uniQure N.V. | 12.83% | 35.50% | 160.86% | -70.14% | 9.31% | -40.28% |
Correlation
The correlation between CNTA and QURE is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2021 | 0.24 |
Fundamentals
CNTA:
-$1.81
QURE:
-$3.58
CNTA:
354.44
QURE:
87.14
CNTA:
$15.00M
QURE:
$18.09M
CNTA:
$15.00M
QURE:
$13.42M
CNTA:
-$227.27M
QURE:
-$164.53M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CNTA vs. QURE — Risk / Return Rank
CNTA
QURE
CNTA vs. QURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Centessa Pharmaceuticals Limited (CNTA) and uniQure N.V. (QURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CNTA | QURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.33 | ||
| Sortino ratioReturn per unit of downside risk | +2.47 | ||
| Omega ratioGain probability vs. loss probability | 1.69 | 1.43 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 8.90 | 0.65 | +8.25 |
| Martin ratioReturn relative to average drawdown | 24.63 | 1.06 | +23.57 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CNTA | QURE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.54 | 0.21 | +3.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | -0.04 | +0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.07 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.18 | 0.05 | +0.13 |
Drawdowns
CNTA vs. QURE - Drawdown Comparison
The maximum CNTA drawdown since its inception was -88.19%, smaller than the maximum QURE drawdown of -95.40%. Use the drawdown chart below to compare losses from any high point for CNTA and QURE.
Loading charts...
Drawdown Indicators
| CNTA | QURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.19% | -95.40% | +7.21% |
Max Drawdown (1Y)Largest decline over 1 year | -26.38% | -87.21% | +60.83% |
Max Drawdown (3Y)Largest decline over 3 years | -43.72% | -87.21% | +43.49% |
Max Drawdown (5Y)Largest decline over 5 years | -88.19% | -90.11% | +1.92% |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.40% | — |
Current DrawdownCurrent decline from peak | -0.50% | -67.15% | +66.65% |
Average DrawdownAverage peak-to-trough decline | -51.99% | -56.58% | +4.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.51% | 53.50% | -43.99% |
Volatility
CNTA vs. QURE - Volatility Comparison
The current volatility for Centessa Pharmaceuticals Limited (CNTA) is 0.72%, while uniQure N.V. (QURE) has a volatility of 28.01%. This indicates that CNTA experiences smaller price fluctuations and is considered to be less risky than QURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CNTA | QURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.72% | 28.01% | -27.29% |
Volatility (6M)Calculated over the trailing 6-month period | 44.27% | 92.44% | -48.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.48% | 273.61% | -207.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 72.09% | 154.08% | -81.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.30% | 119.92% | -47.62% |
Dividends
CNTA vs. QURE - Dividend Comparison
Neither CNTA nor QURE has paid dividends to shareholders.
Financials
CNTA vs. QURE - Financials Comparison
This section allows you to compare key financial metrics between Centessa Pharmaceuticals Limited and uniQure N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CNTA and QURE have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QURE has higher volatility (28.01%) compared to CNTA (0.72%). In terms of maximum drawdown, CNTA dropped -88.19% vs QURE's -95.40%.
CNTA currently has the higher Sharpe Ratio (3.54 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CNTA and QURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer